Literature DB >> 18657653

Spontaneous reperfusion in ST-elevation myocardial infarction: comparison of angiographic and electrocardiographic assessments.

Kevin R Bainey1, Yuling Fu, Galen S Wagner, Shaun G Goodman, Allan Ross, Christopher B Granger, Frans Van de Werf, Paul W Armstrong.   

Abstract

INTRODUCTION: Spontaneous reperfusion (SR) in ST-elevation myocardial infarction has traditionally been assessed by coronary angiography. The frequency of SR varies widely in prior studies, and the clinical implications in the modern reperfusion era are unclear. Accordingly, using data from the ASSENT 4 PCI (ASsessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention) study, we undertook a systematic assessment of SR using both electrocardiographic (ECG) and angiographic techniques. METHODS AND
RESULTS: Five hundred eighty-five patients randomized to the primary percutaneous coronary intervention (PCI) arm of ASSENT 4 PCI were studied: all had ECG and thrombolysis in myocardial infarction flow data available approximately 60 minutes after randomization and before PCI. Electrocardiographic SR (>/=70% ST-segment resolution) occurred in 14.9% (87/585) and angiographic SR (thrombolysis in myocardial infarction grade 3) in 14.7% (86/585) of patients. Thirty-day clinical outcomes of patients with ECG SR versus no ECG SR tended to have lower mortality (0% vs 3.4%, P = .091), a lower composite of death/shock/congestive heart failure (6.9% vs 12.2%, P = .148), and significant reductions in death/reinfarction (0% vs 5.6%, P = .014). By contrast, no such differences were evident in patients with angiographic SR versus no SR for death (2.3% vs 3.0%, P = 1.00), death/shock/congestive heart failure (9.3% vs 11.8%, P = .498), or death/reinfarction (2.3% vs 5.2%, P = .409).
CONCLUSIONS: Whereas the frequency of SR was comparable using either ECG or angiographic criteria, clinical outcomes were best aligned with ECG SR. These data support the role of the ECG in assessing reperfusion and likely reflect the overall impact of myocardial perfusion versus infarct-related artery epicardial patency alone.

Entities:  

Mesh:

Year:  2008        PMID: 18657653     DOI: 10.1016/j.ahj.2008.03.018

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  11 in total

1.  Initial electrocardiogram as determinant of hospital course in ST elevation myocardial infarction.

Authors:  Michael A Millard; Vijaiganesh Nagarajan; Luke C Kohan; Robert C Schutt; Ellen C Keeley
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-01-03       Impact factor: 1.468

2.  Restoration of microcirculatory patency after myocardial infarction: results of current coronary interventional strategies and techniques.

Authors:  Marlos R Fernandes; R David Fish; John Canales; Jonathan Aliota; Guilherme V Silva; Emerson C Perin; Macarthur A Elayda; James M Wilson
Journal:  Tex Heart Inst J       Date:  2012

3.  Sonothrombolysis Augments Reperfusion in ST-Elevation Myocardial Infarction With Primary Percutaneous Coronary Intervention: Insights From the SONOSTEMI Study.

Authors:  Kevin R Bainey; Ahmed Abulhamayel; Amir Aziz; Harald Becher
Journal:  CJC Open       Date:  2022-03-12

4.  Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.

Authors:  Uwe Zeymer; Kurt Huber; Yuling Fu; Allan Ross; Christopher Granger; Patrick Goldstein; Frans van de Werf; Paul Armstrong
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

Review 5.  Spontaneous Reperfusion in Patients with Transient ST-Elevation Myocardial Infarction-Prevalence, Importance and Approaches to Management.

Authors:  Mohamed Farag; Marta Peverelli; Nikolaos Spinthakis; Ying X Gue; Mohaned Egred; Diana A Gorog
Journal:  Cardiovasc Drugs Ther       Date:  2021-07-10       Impact factor: 3.727

6.  Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI.

Authors:  Tim Tödt; Eva Maret; Joakim Alfredsson; Magnus Janzon; Jan Engvall; Eva Swahn
Journal:  BMC Cardiovasc Disord       Date:  2012-02-23       Impact factor: 2.298

7.  Outcomes of Patients Presenting With Clinical Indices of Spontaneous Reperfusion in ST-Elevation Acute Coronary Syndrome Undergoing Deferred Angiography.

Authors:  Paul Fefer; Roy Beigel; Shaul Atar; Doron Aronson; Arthur Pollak; Doron Zahger; Elad Asher; Zaza Iakobishvili; Nir Shlomo; Ronny Alcalai; Michal Einhorn-Cohen; Amit Segev; Ilan Goldenberg; Shlomi Matetzky
Journal:  J Am Heart Assoc       Date:  2017-07-25       Impact factor: 5.501

Review 8.  Role, Laboratory Assessment and Clinical Relevance of Fibrin, Factor XIII and Endogenous Fibrinolysis in Arterial and Venous Thrombosis.

Authors:  Vassilios P Memtsas; Deepa R J Arachchillage; Diana A Gorog
Journal:  Int J Mol Sci       Date:  2021-02-02       Impact factor: 5.923

9.  The association between T wave inversion in leads with ST-elevation and patency of the infarct-related artery.

Authors:  Abdolmohammad Ranjbar; Bahram Sohrabi; Seyyed-Reza Sadat-Ebrahimi; Samad Ghaffari; Babak Kazemi; Naser Aslanabadi; Babak Seyvani; Reza Hajizadeh
Journal:  BMC Cardiovasc Disord       Date:  2021-01-12       Impact factor: 2.298

10.  Influence of angiographic spontaneous coronary reperfusion on long-term prognosis in patients with ST-segment elevation myocardial infarction.

Authors:  Xiaoming Li; Boyu Li; Jing Gao; Yunfei Wang; Song Xue; Dachuan Jiang; Qi Hua; Jing Li
Journal:  Oncotarget       Date:  2017-07-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.